Home/ Supplements/ Omega 3/ Dr. Sears' Private Label Primal Force Ul...

Dr. Sears' Private Label Primal Force Ultra Omeganol

product on market Softgel Capsule Primal Force Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 38% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

This formula contains omega-3 fatty acids and gamma-linolenic acid, which are supported by strong evidence for supporting cardiovascular health and managing inflammation. Research indicates these essential fatty acids contribute to overall cellular function and lipid balance. The evidence coverage for this specific blend is limited.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Dr. Sears' Private Label Primal Force Ultra Omeganol
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Softgel(s)
Serving Size
Other Combinations
Product Type
38%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Calories
11 Calorie(s)
Total Fat
1 Gram(s) (2% DV)
Cholesterol
Gamma-Linolenic Acid
100 mg
Market median: 750.0mg (447 products) 393 studies (A:18, B:204)
Market median: 750.0mg (447 products) 393 studies (A:18, B:204)
Market median: 750.0mg (447 products) 393 studies (A:18, B:204)
2.5 mg
Market median: 4.0mg (47 products)

Other Ingredients

Gelatin Glycerin purified Water Lemon Oil extra virgin Olive Oil Mixed Tocopherols Citric Acid Ascorbyl Palmitate Rosemary extract
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Info

Product Information

Warnings & Precautions

Contains fish: Alaska Pollock and/or Pacific Whiting, Shellfish: Krill.

Formulation Notes

Contains fish: Alaska Pollock and/or Pacific Whiting, Shellfish: Krill.

With AlaskOmega, Calamarine, Superba Krill Oil

Metadata

Product Details

DSLD Entry Date2019-09-24
Product TypeOther Combinations
FormSoftgel Capsule
DSLD ID206523
Data Updated2026-04-11
Research

Research Evidence

495
Research Sources
56
Avg Quality
222
Meta Analysis
104
Clinical Trial
72
Rct
69
Systematic Review
11
Guideline
5
Cochrane Review
5
Regulatory Source
3
Narrative Review
1
Openfda Safety
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Omega-3 fatty acid addition during pregnancy
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Omega-3 fatty acids for depression in adults
Systematic Review The Cochrane database of systematic reviews 2021 PubMed DOI
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Non-immunosuppressive treatment for IgA nephropathy
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Omega-3 fatty acid supplementation for depression in children and adolescents
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Interventions for fatigue and weight loss in adults with advanced progressive illness
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Motor control exercise for chronic non-specific low-back pain
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
View all evidence for Omega 3 →
Compare

Similar Products

View all Omega 3 products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.